Overview

This trial is active, not recruiting.

Conditions venous thromboembolism, venous thrombosis
Treatments nurse education in contemporary format, nurse education in traditional format
Sponsor Johns Hopkins University
Collaborator Patient Centered Outcome Research Institute
Start date July 2014
End date July 2015
Trial size 900 participants
Trial identifier NCT02301793, NA_00043860

Summary

As part of mandatory on-going nursing education, the investigators have incorporated identical information into two distinct web-based learning formats - the traditional linear PowerPoint format (with voice-over) and a new interactive format developed with central nursing education.

The investigators will cluster randomize nurses by floor to receive either the traditional education or the new interactive education, and evaluate the impact on administration of VTE prophylaxis doses administered by nurses before and after education. All nurses on a floor will receive the same educational format. If one method of education results in statistically significant improvement in VTE prophylaxis administration, the investigators will cross over to deliver the superior education format to all nurses who originally were given the less effective method.

United States No locations recruiting
Other Countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking double blind (subject, outcomes assessor)
Primary purpose prevention
Arm
(Experimental)
Nurses in this arm received education about venous thromboembolism (VTE) in a web-based contemporary interactive format. Intervention: Nurse education in contemporary format
nurse education in contemporary format
Education about VTE was delivered through a web-based contemporary interactive format
(Active Comparator)
Nurses in this arm received education about venous thromboembolism (VTE) in a web-based traditional linear PowerPoint format with voice over. Intervention: Nurse education in traditional format
nurse education in traditional format
Education about VTE was delivered through a web-based traditional linear Powerpoint format with voice over.

Primary Outcomes

Measure
Non administration of prescribed VTE prophylaxis medication doses
time frame: 3-12 months after end of study

Secondary Outcomes

Measure
Rates of all VTE among hospitalized patients
time frame: 3-12 months after end of study
Rates of Deep Vein Thrombosis (DVT) among hospitalized patients
time frame: 3-12 months after end of study
Rates of Pulmonary Embolism (PE) among hospitalized patients
time frame: 3-12 months after end of study
Proportion of Non administration of prescribed VTE prophylaxis medication doses which are documented as patient refusal
time frame: 3-12 months after end of study

Eligibility Criteria

Male or female participants of any age.

Inclusion Criteria: - Nurses on selected surgical and medical floors at Johns Hopkins Hospital Exclusion Criteria:

Additional Information

Official title Educating Nurses About Venous Thromboembolism Prevention
Principal investigator Elliott R Haut, MD PhD
Description BACKGROUND - In an attempt to improve venous thromboembolism (VTE) prophylaxis adherence we carried out qualitative studies to obtain patients' viewpoints on how nurses should be educated about VTE prevention and to assess nurses' beliefs and perceptions about pharmacologic VTE prophylaxis - We observed deficiencies in nurses' knowledge and misconceptions about VTE prophylaxis that likely lowers adherence to administration of prescribed VTE prophylaxis doses - As a part of our original Patient-Centered Outcomes Research Institute (PCORI) proposal, we planned to educate nurses to address the observed deficiencies and misconceptions and improve their ability to communicate effectively with patients - Historically, nurse education has been done via a linear, PowerPoint-based platform with voice-over but with no interactive component (TRADITIONAL) - A newer platform for nurse education became available for use and includes scenario-based teaching, ongoing assessment, and immediate remediation. Most importantly, it is a highly interactive product (CONTEMPORARY) STUDY DESIGN AND ANALYTIC PLAN - Research hypotheses - Primary: Nurse participants who receive either of these interventions will improve administration of prescribed VTE prophylaxis evidenced by a decrease in frequency of non-administered doses of VTE prophylaxis, compared with their frequency at baseline. - Secondary: Nurse participants who receive the contemporary education format will have a larger decrease in frequency of missed doses of VTE prophylaxis compared with those who participate in the traditional education format. - Study Design - Cluster Randomized Trial 21 floors, block randomized by floor type (medicine [n=11] vs. surgery [n=10]) and (ICU [n=5] vs. non-ICU [n=16]) All nurses on each floor are assigned the same education type to mitigate issues related to contamination if nurses discuss the education with their colleagues - Primary Outcome measure: Proportion of non-administered doses of pharmacological VTE prophylaxis (dose level) - Secondary Outcome Measures: - Proportion of doses documented as missed due to patient refusal (dose level) - Proportion of patients with any VTE (patient level) - Proportion of patients with Deep Vein Thrombosis (DVT) (patient level) - Proportion of patients with Pulmonary Embolism (PE) (patient level) - Analytic methods - Primary analyses - Intention-to-treat (includes all nurses assigned, whether or not they completed the education) Is there a difference between units allocated to either of the interventions comparing their outcome measure to their baseline measure? Is there a difference comparing those who received the contemporary education format vs. the traditional education format? - Secondary analysis - Per protocol (includes only nurses who completed the education) Do nurses who receive education perform better (improved administration of prescribed VTE prophylaxis) than those who did not? Do nurses who received the education in the contemporary format perform better than those who received it in the traditional format
Trial information was received from ClinicalTrials.gov and was last updated in November 2015.
Information provided to ClinicalTrials.gov by Johns Hopkins University.